Upgrade

CollPlant Biotechnologies Ltd.

CLGN

Last
$3.51
Day
-11.4%
1y
-83.0%
5y
-97.6%
52w
-85.2%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-2546d
EMA 21
3.71
EMA 50
3.63
EMA 200
7.28
20d high
-16.9%
5y high
-98.3%
5y range
1th
Website · 39 employees · Israel

Positions held

Your positions

CLGN isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
3
Hold
watch
Signal
Neutral
Target
$4.75
Stop
$3.32
Stop distance
5.4%
Target vs last
+35.3%

Fundamentals

Market cap$7.51MEnterprise value$5.84MTrailing P/E—Forward P/E-10.18
PEG—Price / book1.95Beta0.76Dividend yield0.00%
Revenue growth-39.7%Earnings growth—Gross margin0.0%Operating margin-24.4%
Profit margin0.0%ROE-1.6%ROA-62.9%Debt / equity0.90
Current ratio1.57Free cash flow-$6.89MAnalyst recommendationnoneMean target—
52w high$26.8052w low$2.64

Quarterly

2026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.1M$0.1M$0.1M$0.2M$2.1M
Op margin-4267.1%-5250.0%-4554.5%-1775.4%-80.2%
Net income-$3.1M-$3.2M-$3.5M-$3.3M-$1.5M
Gross margin-332.9%-220.0%-249.4%-3.9%90.9%
Gross profit-$0.2M-$0.1M-$0.2M-$0.0M$1.9M
Operating income-$3.1M-$3.1M-$3.5M-$3.2M-$1.6M
  • Revenue +22% vs prior quarter ($0.1M vs $0.1M).
  • Gross margin -332.9% (was -220% prior quarter).
  • Operating margin expanded to -4267.1%.

Yearly (6y)

2025202420232022
Revenue$2.4M$0.5M$11.0M$0.3M
Op margin-484.3%-3349.7%-68.5%-5718.1%
Net income-$11.5M-$16.6M-$7.0M-$16.9M
Gross margin64.8%-215.5%81.8%-33.8%
Gross profit$1.5M-$1.1M$9.0M-$0.1M
Operating income-$11.5M-$17.3M-$7.5M-$17.1M
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

CLGN · daily+3.1% over 13 sessions
Close EMA21 EMA50 EMA200
3.193.543.904.264.622026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$3M-$2M-$1M$1M$2M-5250%-2580%91%2025-Q12025-Q22025-Q32025-Q42026-Q1